REVESTIVE

Google image searchProduct monograph

Active ingredient

teduglutide, 5 MG/VIAL

DIN: 02445727

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: KIT INCLUDES 5MG POWDER IN VIAL & 0.5ML DILUENT IN PREFILLED SYRINGE

Schedule: Prescription / Schedule D

Company: TAKEDA CANADA INC

Date: 13-OCT-2021

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AX — Various alimentary tract and metabolism products (ATC, ATC/DDD)
• A16AX08 — TEDUGLUTIDE (ATC/DDD)

Reference brand drug: Revestive

External Links for Revestive

Search on Google

• Revestive side effects
• Revestive dosage
• teduglutide side effects
• teduglutide dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find revestive photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.